Search Results - Ruddell, Alisa

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The Activity and Toxicity of Dasatinib in Relapsed or Plateau-Phase Multiple Myeloma

    The Activity and Toxicity of Dasatinib in Relapsed or Plateau-Phase Multiple Myeloma by Wildes, Tanya M., Ruddell, Alisa, Gao, Feng, Uy, Geoffrey, Cashen, Amanda, Abboud, Camille, Westervelt, Peter, Dipersio, John F., Vij, Ravi

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Tolerability of PTK787/ZK 222584 in a Phase II Study of Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem Cell Transplant

    Tolerability of PTK787/ZK 222584 in a Phase II Study of Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem C... by Mosley, James C., Peles, Shachar, Ruddell, Alisa, Gao, Feng, Abboud, Camille, Cashen, Amanda, Uy, Geoffrey, Westervelt, Peter, DiPersio, John F., Vij, Ravi

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial

    The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial by Gotlib, Jason, George, Tracy I., Corless, Chris, Linder, Andrea, Ruddell, Alisa, Akin, Cem, DeAngelo, Daniel J., Kepten, Ilana, Lanza, Carlo, Heinemann, Heidrun, Yin, Ophelia, Gallagher, Neil, Graubert, Tim

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Phase II Trial of the Tyrosine Kinase Inhibitor PKC412 in Advanced Systemic Mastocytosis: Preliminary Results

    Phase II Trial of the Tyrosine Kinase Inhibitor PKC412 in Advanced Systemic Mastocytosis: Preliminary Results by Gotlib, Jason, George, Tracy I., Linder, Andrea, Ruddell, Alisa, Quesada, Sylvia, Akin, Cem, DeAngelo, Daniel J., Cohen, Pamela, Graubert, Timothy

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma

    The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma by Uy, GL, Tomasson, MH, Ruddell, A, DiPersio, JF, Vij, R

    Published in Haematologica (Roma)
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Low Dose Clofarabine Causes Significant Hematologic Toxicity in a Phase II Study of Relapsed or Refractory Multiple Myeloma

    Low Dose Clofarabine Causes Significant Hematologic Toxicity in a Phase II Study of Relapsed or Refractory Multiple Myeloma by Uy, Geoffrey L., Ruddell, Alisa M., Devine, Steven M., Tomasson, Michael H., DiPersio, John F., Vij, Ravi

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: